A 12-week Digital Physical Activity Programme, With or Without Physical Education Support for Type 2 Diabetes Patients.
NCT ID: NCT06402578
Last Updated: 2024-05-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
60 participants
INTERVENTIONAL
2024-06-30
2025-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy of a Nutritional Education Strategy and Physical Exercise on the Gut Microbiota in Type 2 Diabetics
NCT05261373
Exercise and Diet in Type 2 Diabetic Women
NCT00763074
HOme-Based Exercise for Patients With Type 2 Diabetes
NCT03103126
Promoting Physical Activity Among Patients With Type 2 Diabetes
NCT00547027
Diabetes Exercise and Lifestyle Trial
NCT00877864
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control Group,
Control Group, will be issued with a smartwatch that is paired with a freely accessible App called Alexia® to record their PA. They will be asked to carry on with their daily activity and to record when they do any of their own physical activities that they do themselves routinely on an everyday basis during the 12 week study. They will not receive a 12 week PA programme.
No interventions assigned to this group
Intervention 1
Intervention 1, will be provided with a 12 week PA programme and asked to record their PA while they follow the programme during the 12 week study.
HbA1c testing
Bloods will be take pre and post 12 week intervention.
Intervention 2
Intervention 2, will also be provided with the same 12 week PA program and asked to record their PA while they follow the programme during the 12 week study. The participants in this group will also get support from a physical activity professional (PAP) who will be monitoring their 12 week journey. The PAP will be prompting the participant with weekly information as to why they are doing these exercises as well as supporting the participants to continue their programme as soon as non-adherence to the exercise program becomes apparent during the 12 week study.
HbA1c testing
Bloods will be take pre and post 12 week intervention.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
HbA1c testing
Bloods will be take pre and post 12 week intervention.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 18+ years.
* Uses the English language as a primary or secondary language with the ability to read and write.
* Lives in the United Kingdom.
* Has no medical reason preventing participation in regular physical activity.
* Has a SMART phone with access to the internet.
Exclusion Criteria
* Cardiac or cardiovascular surgery in the past 6 months.
* Musculoskeletal issues that could be aggravated whilst participating in regular physical activity.
* Presently participating in a weight loss programme.
* Unable to commit to the 12-week feasibility study.
18 Years
99 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Queen Margaret University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Phil Calvert
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Philip Calvert, MSc
Role: PRINCIPAL_INVESTIGATOR
PhD student
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Queen Margret University Edinburgh
Edinburgh, Musselburgh, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
QMU-IRAS ID: 327162
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.